Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphoma (HL)”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)UnknownNCT01300156
What this trial is testing

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
National Cancer Center, Korea 37
Testing effectiveness (Phase 2)Study completedNCT02939014
What this trial is testing

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Who this might be right for
Hodgkin DiseaseLymphoma, Large-Cell, Anaplastic
Takeda 39
Not applicableLooking for participantsNCT06263530
What this trial is testing

Prognostic Significance of ctDNA in HL

Who this might be right for
Prognostic Cancer Model
Interni hematologicka klinika FNKV 500
Testing effectiveness (Phase 2)Study completedNCT00061672
What this trial is testing

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin's Lymphoma
Abbott 67
Early research (Phase 1)Study completedNCT01705847
What this trial is testing

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Gilead Sciences 39
Not applicableStudy completedNCT07145125
What this trial is testing

Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
University Hospital, Bordeaux 222
Testing effectiveness (Phase 2)Study completedNCT02243436
What this trial is testing

Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
CLASSICAL HODGKIN LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 67
Testing effectiveness (Phase 2)Study completedNCT01393106
What this trial is testing

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Gilead Sciences 25
Testing effectiveness (Phase 2)Study completedNCT01523847
What this trial is testing

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02690545
What this trial is testing

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

Who this might be right for
LymphomaLymphoma, Non-HodgkinImmune System Diseases+5 more
UNC Lineberger Comprehensive Cancer Center 38
Early research (Phase 1)Active Not RecruitingNCT03602157
What this trial is testing

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Who this might be right for
LymphomaImmune System DiseasesImmunoproliferative Disorders+10 more
UNC Lineberger Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Not applicableStudy completedNCT05066555
What this trial is testing

Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Ended earlyNCT02763254
What this trial is testing

Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

Who this might be right for
Hodgkin LymphomaLymphoma, Large B-Cell, DiffusePost-transplant Lymphoproliferative Disorder
Cell Medica Ltd 1
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Testing effectiveness (Phase 2)Study completedNCT02298283
What this trial is testing

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD

Who this might be right for
Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 40
Testing effectiveness (Phase 2)Looking for participantsNCT06090864
What this trial is testing

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Who this might be right for
Hodgkin LymphomaRelapseRefractory
UNC Lineberger Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT02244021
What this trial is testing

BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV

Who this might be right for
Relapsed/Refractory Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 13
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Not applicableStudy completedNCT02106611
What this trial is testing

Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

Who this might be right for
Hodgkin Lymphoma Survivor
Memorial Sloan Kettering Cancer Center 133
Load More Results